Table 2—

Characteristics of patients and physicians (%) based on U.S. patient-physician encounters* for oral antidiabetic drugs, 1990, 1996, and 2001

1990
1996
2001
MaleFemaleMaleFemaleMaleFemale
Patient age (years)
<20000000
20–29011111
30–39323455
40–4010912121514
50–59181522202522
60–69343127272626
70–79252826262122
≥8081481179
% M/F435748524951
Therapy
 New81517
 Continued928583
Concomitant drugs
 Used alone927861
 Used with:82239
  Insulin459
  Oral hypoglycemic<11529
Physician specialty
Internal medicine414139
General family practice363133
Osteopathic medicine81011
Cardiology564
Endocrinology456
All others677
  • Data are %.

  • *

    * For the age/sex distributions, there were 16.7 million antidiabetic drug appearances in 1990, 20.2 million in 1996, and 31.9 million in 2001;

  • concomitant drugs are for the primary indication mentioned;

  • numbers do not add due to rounding and lack of mention of other therapies. Source: IMS Health, National Disease and Therapeutic Index, Plymouth Meeting, PA, extracted June–August, 2002.